Showing results (381-390 of 401) with videos related to

Sort By:
Pageof 41
Molecular Psychiatry|March 30, 2016
Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out miceC Vicidomini, L Ponzoni, D Lim, et al.
RSC Medicinal Chemistry|February 16, 2026
Leveraging fragment-based drug discovery to advance 3D scaffolds into potent ligands: application to the histamine H1 receptorTom Dekker, Oscar P J van Linden, Herman D Lim, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 5, 2009
Nonpeptidergic allosteric antagonists differentially bind to the CXCR2 chemokine receptorPetra de Kruijf, Jane van Heteren, Herman D Lim, et al.
Palliative & Supportive Care|April 22, 2025
Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic reviewMaria I Lapid, Sandeep R Pagali, Andrea L Randall, et al.
Bioorganic & Medicinal Chemistry|May 6, 2009
Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR studiesHerman D Lim, Enade P Istyastono, Andrea van de Stolpe, et al.
British Journal of Cancer|October 29, 2014
Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumorsM Koczywas, P H Frankel, T W Synold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumorsS J Wong, T Karrison, D N Hayes, et al.
Pageof 41